C

CNSP

CNSP

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
67%Neutral
Buy/Sell Ratio100% buys
BearishBullish
CNSP Live QuoteReal-time
$3.92
$0.92(-18.94%)1M
Day Range$3.92 – $4.11
Open$4.06
Previous Close$4.44
Volume4.2K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$5.78M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-17.90
Price to Book0.4
Dividend Yield0.65%
Beta (Volatility)1.01
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $3.92 (23%)
Low: $1.90High: $10.54
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$10.00-93.3% upside

Insider Buys

2

$44K

Insider Sales

0

$0

Total Volume

$44K

3 transactions

Net Activity

+$44K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys1 sells

$4.00M total

C
2

Charles Faith L.

Dir

1 buys0 sells

$34K total

F
3

Fisher Michal

Dir

1 buys0 sells

$10K total

Trading History
CNSP insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

May 18, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.0K$2000.00$4.00M

May 18, 2026

6 months ago

Fisher Michal

Dir

Director
Buy2.0K$5.00$10K

May 18, 2026

6 months ago

Charles Faith L.

Dir

Director
Buy7.1K$4.79$34K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
CNSP Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

CNSP has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for CNSP

Over the last 90 days, corporate insiders at CNSP (CNSP) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $44K.

The net insider activity for CNSP shows a net buying bias of $44K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 2.0K shares valued at $4.00M on May 18, 2026.

Live Market News & Developments
Aggregated real-time headlines for CNSP (CNSP)
6 updates

Cns Pharmaceuticals Stock Price Forecast. Should You Buy CNSP?

StockInvest.us4d ago

CNS Pharmaceuticals, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (CNSP)

Traders Union5d ago

CNSP - Cns Pharmaceuticals Inc Stock Price and Quote

Finviz176d ago

symbol__ Stock Quote Price and Forecast

CNN1008d ago

CNS Pharmaceuticals, Inc. (CNSP) Stock Price, News, Quote & History

Yahoo! Finance Canada2569d ago

CNSP: Cns Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas

Stocktwits2697d ago

FAQs About CNSP Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for CNSP.

Based on SEC Form 4 disclosures, the Insider Confidence Score for CNSP is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 2 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for CNSP is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.